Not sure whether you need BPC-157, TB-500, or both
J Nutr 136, 1652S1659S (2006)
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
It appears as Body Protection Compound-157, BPC157 without the hyphen, or simply BPC
Royal College of Obstetricians and Gynaecologists
However, this convenience comes at a significant cost to efficacy and reliability for systemic research